Elevated doublecortin-like kinase 1 serum levels revert to baseline after therapy in early stage esophageal adenocarcinoma.

Christman, Emily M; Chandrakesan, Parthasarathy; Weygant, Nathaniel; Maple, John T; Tierney, William M; Vega, Kenneth J; Houchen, Courtney W

Christman, Emily M; Chandrakesan, Parthasarathy; Weygant, Nathaniel; Maple, John T; Tierney, William M; Vega, Kenneth J; Houchen, Courtney W.

Afiliação

Christman EM; 1Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK USA.
Chandrakesan P; 1Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK USA.
Weygant N; 2Peggy and Charles Stephenson Cancer Center, Oklahoma City, OK USA.
Maple JT; 1Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK USA.
Tierney WM; 1Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK USA.
Vega KJ; 1Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK USA.
Houchen CW; 3Department of Medicine, Division of Gastroenterology and Hepatology, Augusta University-Medical College of Georgia, 1120 15th Street, AD 2226, Augusta, GA 30912 USA.

Biomark Res ; 7: 5, 2019.

Article em En | MEDLINE | ID: mdl-30899515

Palavras-chave

Cancer stem cell; DCLK1; Doublecortin-like kinase 1; ELISA; Esophageal adenocarcinoma

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google